Amedisys, Inc. (AMED) Misses Q2 EPS by 1c; Cuts FY11 Outlook
Tweet
Share
E-mailGet Alerts AMED Hot Sheet
Price: $100.99 --0%
Financial Fact:
Non-cash compensation: 4.75M
Today's EPS Names:
ALZN, ASPU, USAU, More
Financial Fact:
Non-cash compensation: 4.75M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Amedisys, Inc. (NASDAQ: AMED) reported Q2 EPS of $0.67, $0.01 worse than the analyst estimate of $0.68. Revenue for the quarter came in at $373.7 million versus the consensus estimate of $383.21 million.
Amedisys, Inc. sees FY2011 EPS of $2.20-$2.40, versus the consensus of $2.94. Prior guidance was for $3.00-$3.30. Amedisys, Inc. sees FY2011 revenue of $1.475-$1.5 billion, versus the consensus of $1.58 billion.
Amedisys, Inc. sees FY2011 EPS of $2.20-$2.40, versus the consensus of $2.94. Prior guidance was for $3.00-$3.30. Amedisys, Inc. sees FY2011 revenue of $1.475-$1.5 billion, versus the consensus of $1.58 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lennar Corp. (LEN) Misses Q3 EPS by 10c
- Intuit holds investor day, reaffirms fiscal 2027 guidance
- Yeti outlines growth targets and financial framework through 2030
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot Guidance, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
